Nordic Nanovector AS

Enterome

This biopharmaceutical company develops microbiome-derived immunotherapies for patients with solid and liquid cancers, including non-Hodgkin lymphoma, and inflammatory diseases.

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

Targovax AS (Oncos)

This biotechnology company develops circular RNA therapeutics and oncolytic virus-based immunotherapies for patients with solid tumours and other difficult-to-treat diseases.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Full-Life Technologies

This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Algeta ASA

The company develops alpha-particle emitting radiopharmaceuticals for cancer patients with bone metastases.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.